These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15088533)

  • 1. Familial centronuclear myopathy: a clinical and pathological study.
    Sher JH; Rimalovski AB; Athanassiades TJ; Aronson SM
    Neurology; 1967 Aug; 17(8 Pt 1):727-42. PubMed ID: 15088533
    [No Abstract]   [Full Text] [Related]  

  • 2. Centronuclear myopathy with cardiomyopathy due to recessive titinopathy.
    Martinez-Thompson JM; Winder TL; Liewluck T
    Muscle Nerve; 2019 Apr; 59(4):E26-E27. PubMed ID: 30681174
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical, Electrophysiology, and Pathology Features of Dynamin Centronuclear Myopathy: A Case Report and Review of Literature.
    Verma S; Balasubramanian SB
    J Clin Neuromuscul Dis; 2016 Dec; 18(2):84-88. PubMed ID: 27861221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult- Onset Centronuclear Myopathy.
    Krishnan M; Selvaraj C; Sivakumar S
    J Assoc Physicians India; 2016 Jun; 64(6):81-82. PubMed ID: 27739277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
    Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
    Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant centronuclear myopathy with unique clinical presentations.
    Lee JY; Min JH; Hong YH; Sung JJ; Park SH; Park SH; Lee KW; Park KS
    J Korean Med Sci; 2007 Dec; 22(6):1098-101. PubMed ID: 18162732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial alterations in dynamin 2-related centronuclear myopathy.
    Zanoteli E; Vergani N; Campos Y; Vainzof M; Oliveira AS; d'Azzo A
    Arq Neuropsiquiatr; 2009 Mar; 67(1):102-4. PubMed ID: 19330221
    [No Abstract]   [Full Text] [Related]  

  • 10. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
    Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
    Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital myopathies: an update.
    Claeys KG
    Dev Med Child Neurol; 2020 Mar; 62(3):297-302. PubMed ID: 31578728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histologic findings in autosomal centronuclear myopathy.
    Jeannet PY; Bassez G; Eymard B; Laforêt P; Urtizberea JA; Rouche A; Guicheney P; Fardeau M; Romero NB
    Neurology; 2004 May; 62(9):1484-90. PubMed ID: 15136669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular aggregate myopathy causing progressive fatiguable weakness.
    Fan Q; Gwathmey K; Du X; Seth A; Corse A
    Pract Neurol; 2024 Mar; 24(2):137-140. PubMed ID: 37923376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new congenital myopathy.
    Castro-Gago M; Pintos-Martínez E; Eirís-Puñal J
    Acta Paediatr; 2002; 91(6):727-8. PubMed ID: 12162615
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of adult-onset centronuclear myopathy.
    Na SJ; Kim TS; Choi YC
    Yonsei Med J; 2004 Apr; 45(2):352-5. PubMed ID: 15119013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myopathy with tubular aggregates: report on two siblings from India.
    Narayanappa G; Nalini A; Thaha F
    J Child Neurol; 2009 Jul; 24(7):874-8. PubMed ID: 19240046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
    Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
    Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
    Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
    Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.